Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00489632 · ClinicalTrials.gov registry record

Children's Resiliency, Adjustment, and Coping

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
66
Enrollment target

NCT00489632: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT00489632 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00489632 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
66 participants
Enrollment target

Study Summary

Overall Objective: The overall objective of this cross-sectional psychosocial study is to examine illness-related factors, family context factors, and child resiliency as predictors or correlates of child adjustment to leukemia treatment. Primary Objective 1: 1(a): To examine illness-related factors (i.e., child's health and physical functioning and severity of the child's illness) as predictors of child psychological adjustment to leukemia. 1(b): To examine relapse status as a grouping variable affecting child psychological adjustment to leukemia. 1(c): To examine stage of treatment as a grouping variable affecting child psychological adjustment to leukemia. Primary Objective 2: -To examine family context factors (i.e., family psychosocial risk and parental emotional distress) as correlates of child psychosocial adjustment to leukemia treatment. Primary Objective 3: -To examine child resiliency as a predictor of child psychological adjustment to leukemia treatment. Secondary Objectives: * One secondary objective of the study is to examine parental distress as a moderator affecting parental report of child adjustment to leukemia as compared to the child's self-report of adjustment. * Another secondary objective of the study is to develop a model by which the relative contribution of each predictor variable (as determined by analyses of primary objectives) as well as their interrelatedness can be understood in relation to child psychosocial adjustment. * A third secondary objective of the study is to examine demographic variables as covariates in the main analyses. These variables include: age, grade, site, gender, ethnicity, type of leukemia, staging, time spent in treatment, age at diagnosis, and whether the child is undergoing standard or experimental treatment.

Interventions

  • BEHAVIORAL Questionnaire

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2006-04
Est. Completion 2011-01
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00489632 record still lists

NCT00489632 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.

NCT00489632 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00489632 about?

NCT00489632 is a clinical study titled "Children's Resiliency, Adjustment, and Coping". Overall Objective: The overall objective of this cross-sectional psychosocial study is to examine illness-related factors, family context factors, and child resiliency as predictors or correlates of child adjustment to leukemia treatment. Primary Objective 1: 1(a): To examine illness-related fact...

What is the current status of trial NCT00489632?

This trial is currently completed. The enrollment target is 66 participants. The study started on 2006-04. Estimated completion is 2011-01.

What interventions are being tested in trial NCT00489632?

The interventions under investigation include: Questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT00489632?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00489632, the US trial registry maintained by the National Library of Medicine. NCT00489632 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.